Joakim Øverbø

  • MD
 

Publications 2024

Dudman SG, Klundby I, Øverbø J, Numanovic S, Nilsen M, Lind A, Holberg-Petersen M, Landaas ET (2024)
Trends in the enterovirus surveillance in Oslo, Norway before and during the COVID-19 pandemic
Frontiers in Virology, 3, 1-9
DOI 10.3389/fviro.2023.1343781, PublikaID 492

Publications 2023

Øverbø J, Aziz A, Zaman K, Clemens J, Halle Julin C, Qadri F, Stene-Johansen K, Biswas R, Islam S, Rahman Bhuiyan T, Haque W, Sandbu S, Elahee ME, Ali M, Dembinski JL, Dudman S (2023)
Immunogenicity and safety of a two-dose regimen with hepatitis E virus vaccine in healthy adults in rural Bangladesh: A randomized, double-blind, controlled, phase 2/pilot trial
Vaccine, 41 (5), 1059-1066
DOI 10.1016/j.vaccine.2022.12.064, PubMed 36599736

Publications 2022

Aziz AB, Øverbø J, Dudman S, Julin CH, Kwon YJG, Jahan Y, Ali M, Dembinski JL (2022)
Hepatitis E Virus (HEV) Synopsis: General Aspects and Focus on Bangladesh
Viruses, 15 (1)
DOI 10.3390/v15010063, PubMed 36680103

Øverbø J, Aziz A, Zaman K, Julin CH, Qadri F, Stene-Johansen K, Biswas R, Islam S, Bhuiyan TR, Haque W, Sandbu S, Dembinski JL, Dudman S (2022)
Stability and Feasibility of Dried Blood Spots for Hepatitis E Virus Serology in a Rural Setting
Viruses, 14 (11)
DOI 10.3390/v14112525, PubMed 36423134

Publications 2020

Zaman K, Dudman S, Stene-Johansen K, Qadri F, Yunus M, Sandbu S, Gurley ES, Overbo J, Julin CH, Dembinski JL, Nahar Q, Rahman A, Bhuiyan TR, Rahman M, Haque W, Khan J, Aziz A, Khanam M, Streatfield PK, Clemens JD (2020)
HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh
BMJ Open, 10 (1), e033702
DOI 10.1136/bmjopen-2019-033702, PubMed 31959609

Publications 2019

Julin CH, Hjortaas K, Dembinski JL, Sandbu S, Overbo J, Stene-Johansen K, Dudman S (2019)
Hepatitis E in Pregnant Women and the Potential Use of HEV Vaccine to Prevent Maternal Infection and Mortality
Curr. Trop. Med. Rep., 6 (4), 197-204
DOI 10.1007/s40475-019-00193-y

Publications 2018

Nascimento MSJ, Pereira SS, Teixeira J, Abreu-Silva J, Oliveira RMS, Myrmel M, Stene-Johansen K, Øverbø J, Gonçalves G, Mesquita JR (2018)
A nationwide serosurvey of hepatitis E virus antibodies in the general population of Portugal
Eur J Public Health, 28 (4), 720-724
DOI 10.1093/eurpub/ckx213, PubMed 29237007

Publications 2017

Aberra H, Gordien E, Desalegn H, Berhe N, Medhin G, Mekasha B, Gundersen SG, Gerber A, Stene-Johansen K, Øverbø J, Johannessen A (2017)
Hepatitis delta virus infection in a large cohort of chronic hepatitis B patients in Ethiopia
Liver Int, 38 (6), 1000-1009
DOI 10.1111/liv.13607, PubMed 28980394

Publications 2016

Løvdahl A, Øverbø J (2016)
A patient between 20 - 30 years of age with jaundice and pain in joints and muscles
Tidsskr Nor Laegeforen, 136 (19), 1651-1652
DOI 10.4045/tidsskr.15.1094, PubMed 27790894

Mesquita JR, Myrmel M, Stene-Johansen K, Øverbø J, Nascimento MS (2016)
A Public Health initiative on hepatitis E virus epidemiology, safety and control in Portugal--study protocol
BMC Infect Dis, 16, 17
DOI 10.1186/s12879-016-1341-5, PubMed 26774897

Stene-Johansen K, Yaqoob N, Overbo J, Aberra H, Desalegn H, Berhe N, Johannessen A (2016)
Dry Blood Spots a Reliable Method for Measurement of Hepatitis B Viral Load in Resource-Limited Settings
PLoS One, 11 (11), e0166201
DOI 10.1371/journal.pone.0166201, PubMed 27820845

Page visits: 3835